BRPI0605832A2 - glicosìdeos de antraciclina liofilizados estáveis - Google Patents

glicosìdeos de antraciclina liofilizados estáveis

Info

Publication number
BRPI0605832A2
BRPI0605832A2 BRPI0605832-9A BRPI0605832A BRPI0605832A2 BR PI0605832 A2 BRPI0605832 A2 BR PI0605832A2 BR PI0605832 A BRPI0605832 A BR PI0605832A BR PI0605832 A2 BRPI0605832 A2 BR PI0605832A2
Authority
BR
Brazil
Prior art keywords
dried
hydrochloride
anthracycline
stable
anthracycline glycoside
Prior art date
Application number
BRPI0605832-9A
Other languages
English (en)
Inventor
Roberto Arosio
Marco Villa
Simonetta Amati
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Publication of BRPI0605832A2 publication Critical patent/BRPI0605832A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

GLICOSìDEOS DE ANTRACICLINA LIOFILIZADOS ESTáVEIS. A presente invenção fornece sais glicosídeos de antraciclina liofilizados e sais glicosídeos de antraciclina liofilizados estáveis, especialmente o sal hidrocloreto. Além disso, a presente invenção proporciona métodos para estabilizar esses sais glicosídeos de antraciclina e métodos para produzir sais glicosídeos de antraciclina liofilizados estáveis corno, por exemplo, o composto antineoplástico hidrocíoret~o de idarubicina, ou os compostos hidrocloreto de doxorubicina e hidrocloreto de epirubicina.
BRPI0605832-9A 2005-05-11 2006-05-11 glicosìdeos de antraciclina liofilizados estáveis BRPI0605832A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68013905P 2005-05-11 2005-05-11
PCT/US2006/018434 WO2006122309A2 (en) 2005-05-11 2006-05-11 Stable lyophilized anthracycline glycosides

Publications (1)

Publication Number Publication Date
BRPI0605832A2 true BRPI0605832A2 (pt) 2009-05-26

Family

ID=37397341

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0605832-9A BRPI0605832A2 (pt) 2005-05-11 2006-05-11 glicosìdeos de antraciclina liofilizados estáveis

Country Status (9)

Country Link
US (1) US20070004653A1 (pt)
EP (1) EP1814525A2 (pt)
JP (1) JP2008513519A (pt)
KR (1) KR20070088447A (pt)
BR (1) BRPI0605832A2 (pt)
CA (1) CA2606390A1 (pt)
MX (1) MX2007000413A (pt)
TW (1) TW200718426A (pt)
WO (1) WO2006122309A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ563365A (en) * 2005-06-02 2011-02-25 Schering Corp Combination of HCV protease inhibitors with a surfactant
AU2006252519B2 (en) * 2005-06-02 2012-08-30 Merck Sharp & Dohme Corp. HCV protease inhibitors in combination with food
WO2009118754A2 (en) * 2008-03-28 2009-10-01 Astron Research Limited A process for preparing a stable lyophilized composition
DE102011103751A1 (de) * 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
CN103087124B (zh) * 2012-11-21 2016-01-13 浙江海正药业股份有限公司 一种制备阿霉素的方法
US20150087681A1 (en) * 2013-09-25 2015-03-26 Pranav Patel Bendamustine HCL Stable Lyophilized Formulations
CN104861014B (zh) * 2015-06-03 2017-09-29 道中道（菏泽）制药有限公司 一种盐酸表阿霉素结晶的制备方法
CN110483301A (zh) * 2018-06-11 2019-11-22 上海睿升化工科技有限公司 一种2-氧代戊烷-1,5-二甲酸二乙酯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012284A (en) * 1962-11-16 1977-03-15 Societa' Farmaceutici Italia, S.p.A. Process of preparation of antibiotic F.I. 1762 derivatives
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
NO175802C (no) * 1986-12-05 1994-12-14 Erba Farmitalia Fremgangsmåte for fremstilling av en lagringsstabil antracyklinglycosidopplösning
FI883338A7 (fi) * 1987-07-16 1989-01-17 Bristol Myers Squibb Co Doksorubisiinihydrokloridin vesiliuoksia
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
GB9926843D0 (en) * 1999-11-12 2000-01-12 Pharmacia & Upjohn Spa Lipid complex of alkycyclines
KR101059715B1 (ko) * 2002-11-29 2011-08-29 다이닛본 스미토모 세이야꾸 가부시끼가이샤 안정화된 안트라사이클린계 화합물의 동결 건조 제제
CN100412084C (zh) * 2003-07-02 2008-08-20 獀洛克斯股份有限公司 热稳定的结晶盐酸表柔比星及其制造方法

Also Published As

Publication number Publication date
US20070004653A1 (en) 2007-01-04
KR20070088447A (ko) 2007-08-29
EP1814525A2 (en) 2007-08-08
TW200718426A (en) 2007-05-16
WO2006122309A2 (en) 2006-11-16
WO2006122309B1 (en) 2007-09-07
CA2606390A1 (en) 2006-11-16
JP2008513519A (ja) 2008-05-01
WO2006122309A3 (en) 2007-06-28
MX2007000413A (es) 2007-06-15

Similar Documents

Publication Publication Date Title
DOP2011000199A (es) Compuestos heterociclocos y metodos de uso
BRPI0605832A2 (pt) glicosìdeos de antraciclina liofilizados estáveis
BRPI0819995A2 (pt) Válvulas de múltiplas posições para controle de areia e fratura, e métodos de acabamento associados.
BRPI0610359B8 (pt) compostos de diaril-hidantoína, suas composições farmacêuticas e sais farmaceuticamente aceitáveis
WO2007140191A3 (en) Glucose transport inhibitors and methods of use
IL198930A0 (en) Non-standard amino acid conjugates of amphetamine and processes for making and using the same
CO6480930A2 (es) Composiciones y procedimientos para preparar composiciones inmunogénicas de conjugado de polisacárido capsular de serotipo 5 y 8 de staphylococcus aureus.
NO344947B1 (no) Peptistoffsammensetninger og fremgangsmåter for fremstilling av lyofiliserte sammensetninger som omfatter et peptistoff, samt et sett som omfatter peptistoff sammensetningene.
CY1112511T1 (el) Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline)
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
DK2144515T3 (da) Sødemiddelsammensætning med forbedret smag
WO2008083200A3 (en) Spiroheterocyclic glycosides and methods of use
BRPI0607765A2 (pt) pirazolopirimidinas
GT200600520A (es) Agentes antibacterianos
BRPI0815752A2 (pt) Mimético de peptídeo tipo nap ou mimético de peptídeo tipo sal, composição farmacêutica, e, método para tratar ou prevenir doenças.
AU2022297983A1 (en) Bivalent compounds, conjugates and uses thereof
CR8568A (es) Macrolidos y metodos para producir los mismos
CL2008001689A1 (es) Disposicion de fijacion para el acoplamiento de elementos de arado en maquinas de cultivo agricolas, siendo los elementos de arado,que comprende un elemento de fijacion intermedio formado por un cuerpo macizo que une el elemento de arado con un brazo de soporte.
BRPI0411691A (pt) l-lisina de aztreonam e seus métodos de preparação
GT200600349A (es) Compuestos orgánicos
WO2007016455A3 (en) Compositions and methods using aminoglycosides to bind dna and rna
WO2009069800A1 (ja) 新規アミノグリコシド抗生物質、その製造方法およびその医薬用途
ATE492286T1 (de) Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivität
ATE449102T1 (de) Kristallines azithromycin-l-malat-monohydrat und pharmazeutische zusammensetzung, die dieses enthält
WO2007030802A3 (en) Targeted contrast agents and methods for targeting contrast agents

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.